Aridis Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2023.
  • Aridis Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $263K, a 94.1% decline year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $14.8M, a 57.4% decline from 2021.
  • Aridis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $34.7M, a 300% increase from 2020.
  • Aridis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $8.68M, a 73.8% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $263K -$4.18M -94.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-06-08
Q1 2022 $4.44M -$2.14M -32.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-08
Q1 2021 $6.58M +$6.57M +46914% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $14K +$6K +75% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $8K* Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.